Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released an open letter in response to the settlement of ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Swiss National Bank boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 188,400 ...

Researchers have developed a method that shows how the nervous system and sensory organs are formed in an embryo. By labeling stem cells with a genetic 'barcode', they have been able to follow the ...

Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.

Ultima Genomics, Inc., developer of an ultra-high-throughput sequencing architecture, today announced the launch of its "Count on Us" initiative. During the month of April, Ultima Genomics will ...

Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed ...

Technology Networks spoke to the most productive researcher in spatial transcriptomics, Professor Joakim Lundeberg, about the ...